Imperial College London
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1907-07-08
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.imperial.ac.uk
Feasibility of Improving Risk Stratification in Brugada Syndrome
Completed
- Conditions
- Athletes HeartBrugada SyndromeCardiac ArrestVentricular Ectopic BeatAtrial Fibrillation
- Interventions
- Other: No intervention
- First Posted Date
- 2019-06-20
- Last Posted Date
- 2022-08-17
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 45
- Registration Number
- NCT03992677
- Locations
- 🇬🇧
Hammersmith Hospital, London, United Kingdom
The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth
Phase 1
- Conditions
- Miscarriage in Third TrimesterPreterm BirthMiscarriage in Second TrimesterPreterm LaborPreterm Premature Rupture of MembraneCervical Incompetence
- Interventions
- Combination Product: LACTIN-V
- First Posted Date
- 2019-06-20
- Last Posted Date
- 2020-05-28
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 60
- Registration Number
- NCT03992534
- Locations
- 🇬🇧
Institute of Reproductive Developmental Biology, Hammersmith Hospital, London, United Kingdom
Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection
- First Posted Date
- 2019-06-19
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 8
- Registration Number
- NCT03991780
- Locations
- 🇬🇧
Imperial College NHS Healthcare Trust, London, United Kingdom
Development and Validation of a Tumour Oxygenation Monitoring Probe
- Conditions
- Cancer
- Interventions
- Device: DRS probe
- First Posted Date
- 2019-06-11
- Last Posted Date
- 2019-08-15
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 20
- Registration Number
- NCT03982355
- Locations
- 🇬🇧
Imperial College London, London, Greater London, United Kingdom
Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative The NOVEL Trial
Phase 3
- Conditions
- Neoplasia
- Interventions
- Biological: Gardasill 9™ vaccine
- First Posted Date
- 2019-06-07
- Last Posted Date
- 2019-08-29
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 1000
- Registration Number
- NCT03979014
- Locations
- 🇬🇧
Imperial College London, London, United Kingdom
Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients
Completed
- Conditions
- Adherence, MedicationTransplantation, Kidney
- Interventions
- Behavioral: Focus group
- First Posted Date
- 2019-06-06
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 26
- Registration Number
- NCT03977051
- Locations
- 🇬🇧
Imperial College Renal and Transplant Centre, London, United Kingdom
The British Society of Endovascular Therapy ConformabLe EndoVascular Aneurysm Repair Registry
Completed
- Conditions
- Abdominal Aortic Aneurysm Without Rupture
- First Posted Date
- 2019-05-29
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 105
- Registration Number
- NCT03966521
- Locations
- 🇬🇧
NHS Grampian, Aberdeen, United Kingdom
🇬🇧Bedford Hospital NHS Trust, Bedford, United Kingdom
🇬🇧University Hospitals Dorset NHS Foundation Trust, Bournemouth, United Kingdom
Clinical Assessment of a Novel Advanced Bolus Calculator for Type 1 Diabetes 5
Not Applicable
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Device: ABC4DDevice: Standard Bolus Calculator
- First Posted Date
- 2019-05-24
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 37
- Registration Number
- NCT03963219
- Locations
- 🇬🇧
Imperial College Clinical Research Facility, London, United Kingdom
Intelligent Operating Room
Not Applicable
- Conditions
- Surgery
- Interventions
- Other: pedal-controlled GoSurgeryTMOther: ML-controlled GoSurgeryTMOther: NoGo
- First Posted Date
- 2019-05-20
- Last Posted Date
- 2022-04-11
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 150
- Registration Number
- NCT03955614
- Locations
- 🇬🇧
Imperial College Hospitals NHS Trust, London, United Kingdom
Acute Mycoprotein Effect on Glycaemic Control in South Asians
Not Applicable
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Other: Test food containing different types of dietary protein
- First Posted Date
- 2019-05-14
- Last Posted Date
- 2019-09-17
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 48
- Registration Number
- NCT03949582
- Locations
- 🇬🇧
NIHR Imperial Clinical Research Facility, London, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath